New State Pharmaceutical Company to Tackle Medicine Shortages and Stabilize Prices

The Maldivian government is launching a state-owned pharmaceutical company to resolve chronic medicine shortages and curb rising costs across the archipelago. Minister of Health, Family and Welfare Geela Ali stated that the initiative is designed to ensure the consistent availability of essential drugs and create a more stable pricing environment for patients. Currently, the pharmaceutical landscape is heavily reliant on the private sector, which supplies approximately 70 percent of the country's needs, while the State Trading Organisation (STO) provides the remaining 30 percent. Minister Ali explained that the Maldives' small market size makes it difficult for multiple importers to sustain the supply of the same medicines, often leading to instability in availability. Structural hurdles have further complicated the system. The Minister highlighted that exclusive registration agreements between certain suppliers and the state often block other importers from accessing vital medicines, creating artificial bottlenecks in the supply chain. To combat these issues, the state pharmaceutical company is collaborating with neighboring countries to diversify and secure supply lines. Simultaneously, Aasandha—the national health insurance scheme—is working to implement maximum retail prices to prevent excessive profit margins and protect consumers from price gouging. Access to medication remains one of the most critical challenges in the Maldivian healthcare system. Residents frequently report shortages in island-based pharmacies, limited stock in the capital city of Malé, and concerns regarding the quality and affordability of available drugs. Established in 2025, the state pharmaceutical company is positioned as the central pillar of the government's strategy to achieve pharmaceutical independence. The company has already begun importing its first shipments and distributing them to the market. The government also intends to leverage STO pharmacies across the atolls to improve the last-mile delivery of medicine to remote communities.